RIGHTSIGN
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

RIGHTSIGN Trademark

Serial Number: 79289550 • Registration: 6617139

RIGHTSIGN is a trademark filed by  Hangzhou Biotest Biotech Co., Ltd. on June 10, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

 Hangzhou Biotest Biotech Co., Ltd. (21 trademarks)

17# Futai Road,Zhongtai Street,Yuhang Di
Hangzhou, Zhejiang 311100 , CN

Entity Type: 16

Trademark Details

Filing Date

June 10, 2020

Registration Date

January 18, 2022

Published for Opposition

November 2, 2021

Goods & Services

Chemical-pharmaceutical preparations, namely, Pregnancy testing preparations, Pharmaceutical preparations for the detection and treatment of infectious diseases, Pharmaceutical preparations for the detection and treatment of cardiovascular disease, Medical diagnostic reagents and assays for testing body fluids for the presences of illicit drugs, Pharmaceutical preparations for the detection and treatment of immune system related diseases and disorders; Chemical preparations for pharmaceutical or medical purposes for use in testing fertility levels, for testing for pregnancy, for determining progesterone production, for testing bodily fluids for the presence of infectious diseases, and for conducting diagnostic urine analysis; chemical preparations for the diagnosis of pregnancy; chemical preparations for medical purposes for diagnosing or detecting infectious diseases, early stage pregnancy, tumors, drug use, and in-vitro ovulation; chemical preparations for pharmaceutical purposes, namely, Pregnancy testing preparations, Pharmaceutical preparations for the detection and treatment of infectious diseases, Pharmaceutical preparations for the detection and treatment of cardiovascular disease, Medical diagnostic reagents and assays for testing body fluids for the presences of illicit drugs, Pharmaceutical preparations for the detection and treatment of immune system related diseases and disorders; chemical reagents for medical or veterinary purposes; preparations of microorganisms for medical or veterinary use for use in the treatment and diagnosis of inflammation, cancer, fertility disorders, cardiovascular disease, and infectious diseases; biological preparations for medical purposes use for use in the treatment and diagnosis of inflammation, cancer, fertility disorders, cardiovascular disease, and infectious diseases; drugs for medical purposes, namely, pharmaceutical preparations for the treatment and diagnosis of inflammation, cancer, fertility disorders, cardiovascular disease, and infectious diseases; diagnostic preparations for medical purposes

Massage apparatus; surgical apparatus and instruments; medical apparatus and instruments being a digital polymerase chain reaction (pcr) platform comprising Flow cytometers for medical diagnostic uses for use in detecting, diagnosing and treating cancer and infectious disease and Medical diagnostic polymerase chain reaction (pcr) instruments for the analysis of body fluids for use in detecting, diagnosing and treating cancer and infectious disease; instrument cases fitted for medical instruments and for use by doctors; apparatus for use in medical analysis being a digital polymerase chain reaction (pcr) platform comprising Flow cytometers for medical diagnostic uses for use in pre-natal screenings and Medical diagnostic polymerase chain reaction (pcr) instruments for the analysis of body fluids for use in pre-natal screenings; testing apparatus for medical purposes being a digital polymerase chain reaction (dPCR) platform comprising Flow cytometers for medical diagnostic uses for testing DNA and RNA samples and Medical diagnostic polymerase chain reaction (pcr) instruments for the analysis of body fluids and testing DNA and RNA samples; diagnostic apparatus for medical purposes being a digital polymerase chain reaction (dPCR) platform comprising Flow cytometers for medical diagnostic uses for use in detecting, diagnosing and treating cancer and infectious disease and Medical diagnostic polymerase chain reaction (pcr) instruments for the analysis of body fluids for use in detecting, diagnosing and treating cancer and infectious disease

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 18, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 27, 2022 FICS
FINAL DISPOSITION PROCESSED
Jun 27, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 18, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 18, 2022 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jan 10, 2022 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 22, 2021 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Dec 22, 2021 OPNR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 14, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Nov 14, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 14, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 14, 2021 REAP
NOTIFICATION PROCESSED BY IB
Nov 8, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 2, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 2, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 13, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 13, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 13, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 29, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 18, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 18, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 18, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 18, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 16, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 15, 2021 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 15, 2021 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 9, 2021 GNFN
FINAL REFUSAL E-MAILED
Jul 9, 2021 GNFR
FINAL REFUSAL WRITTEN
Jul 9, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 16, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 16, 2021 CRFA
ASSIGNED TO LIE
Jun 9, 2021 ALIE
NOTICE OF REVIVAL - E-MAILED
Mar 18, 2021 NREV
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 17, 2021 TROA
PETITION TO REVIVE-GRANTED
Mar 17, 2021 PETG
TEAS PETITION TO REVIVE RECEIVED
Mar 17, 2021 PROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 17, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 17, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 17, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 17, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 17, 2021 COAR
REFUSAL PROCESSED BY IB
Sep 27, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Sep 5, 2020 RFCS
REFUSAL PROCESSED BY MPU
Aug 28, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 15, 2020 RFCR
NON-FINAL ACTION WRITTEN
Aug 14, 2020 CNRT
ASSIGNED TO EXAMINER
Aug 12, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 21, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 17, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 16, 2020 REPR